J. Anim Sci.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online first on August 8, 2007
J. Anim Sci. 1990. doi:10.2527/jas.2007-0219
© 2007 American Society of Animal Science

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jas.2007-0219v1
86/14_suppl/E236    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hausman, G. J.
Right arrow Articles by Azain, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hausman, G. J.
Right arrow Articles by Azain, M. J.
J. Anim Sci., doi: 10.2527/jas.2007-0219
©Copyright, 2007, The American Society of Animal Science


ARTICLE

The influence of thiazolidinediones on adipogenesis in vitro and in vivo: Potential modifiers of intramuscular adipose tissue deposition in meat animals

G. J. Hausman 1*, S. P. Poulos 2, T. D. Pringle 3, M. J. Azain 3

1 USDA, ARS, APRU, Athens, GA, 30605
2 The Coca-Cola Company, Innovation, Ingredient Science, Atlanta, GA, 30313
3 Animal and Dairy Science Department, University of Georgia, Athens, GA. 30602

* To whom correspondence should be addressed. E-mail: Gary.Hausman{at}ARS.USDA.GOV.


   Abstract

Thiazolidinediones (TZD) are insulin sensitizing agents currently used for the treatment of type 2 diabetes and are widely used as adipogenic agents because they are ligands of peroxisome proliferator-activated receptor gamma (PPAR{gamma}), a key adipogenic transcription factor. In vivo and in vitro studies of TZD as potential modifiers of intramuscular or marbling adipogenesis are reviewed. Thiazolidinedione-induced adipogenesis has been reported in numerous cell culture systems including rodent, human, bovine and porcine adipose tissue stromal-vascular (S-V) cell cultures. Studies of porcine S-V cell cultures derived from semitendinosus muscle show that TZD can potentially modify intramuscular or marbling adipogenesis. Preadipocyte recruitment was TZD dependent in muscle (S-V) cultures but TZD independent in adipose S-V cultures. There appear to be differences between adipocytes in muscle and subcutaneous adipose tissue, reminiscent of differences observed in adipocytes from different adipose tissue depots. Troglitazone, a thiazolidinedione, induces marbling adipogenesis without inhibiting myogenesis when cells are grown on laminin pre-coated culture dishes. Additionally, troglitazone treatment does not increase lipid content in porcine adipose tissue or muscle S-V cell cultures. Thiazolidinedione treatment increases lipid content of muscle in rodents and humans; however, rosiglitazone treatment for 49 d in pigs did not influence muscle lipid content and meat quality, but several significant changes in muscle fatty acid composition were observed. Although timing of treatment with TZD needs to be optimized, evidence suggests these compounds may enhance marbling deposition in swine.

Key Words: Thiazolidinedione, Porcine, Marbling, Adipogenesis, Skeletal muscle, Adipose, CCAAT/Enhancer binding protein alpha, Peroxisome proliferator-activated receptor gamma







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Society of Animal Science.